Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.6.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Net revenue $ 181,000 $ 106,000 $ 474,000 $ 277,000
Cost of sales 311,000 202,000 771,000 440,000
Gross loss (130,000) (96,000) (297,000) (163,000)
Operating expenses:        
Selling and administrative expenses 653,000 605,000 1,300,000 1,164,000
Research and development 219,000 469,000 509,000 801,000
Total operating expenses 872,000 1,074,000 1,809,000 1,965,000
Operating loss (1,002,000) (1,170,000) (2,106,000) (2,128,000)
Other income (expense):        
Change in fair value of derivative liabilities 3,000 13,000
Interest expense (36,000) (46,000) (121,000) (96,000)
Net loss $ (1,035,000) $ (1,216,000) $ (2,214,000) $ (2,224,000)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ (0.01) $ (0.01) $ (0.02)
Weighted average number of common shares outstanding - basic and diluted (in shares) 249,931,477 150,825,082 240,449,582 132,681,921